Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding Site

Summary About 10% of all protein kinases are predicted to be enzymatically inactive pseudokinases, but the structural details of kinase inactivation have remained unclear. We present the first structure of a pseudokinase, VRK3, and that of its closest active relative, VRK2. Profound changes to the active site region underlie the loss of catalytic activity, and VRK3 cannot bind ATP because of residue substitutions in the binding pocket. However, VRK3 still shares striking structural similarity with VRK2, and appears to be locked in a pseudoactive conformation. VRK3 also conserves residue interactions that are surprising in the absence of enzymatic function; these appear to play important architectural roles required for the residual functions of VRK3. Remarkably, VRK3 has an “inverted” pattern of sequence conservation: although the active site is poorly conserved, portions of the molecular surface show very high conservation, suggesting that they form key interactions that explain the evolutionary retention of VRK3.

[1]  T. Südhof,et al.  CASK Functions as a Mg2+-Independent Neurexin Kinase , 2008, Cell.

[2]  R. Huber,et al.  Phosphotransferase and substrate binding mechanism of the cAMP‐dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5‐24). , 1993, The EMBO journal.

[3]  Andreas Prlic,et al.  Ensembl 2007 , 2006, Nucleic Acids Res..

[4]  R. Nichols,et al.  Characterization of Three Paralogous Members of the Mammalian Vaccinia Related Kinase Family* , 2004, Journal of Biological Chemistry.

[5]  Ana Sevilla,et al.  p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1 , 2004, Molecular and Cellular Biology.

[6]  G. Barton,et al.  Emerging roles of pseudokinases. , 2006, Trends in cell biology.

[7]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[8]  Claudio R. Santos,et al.  Modulation of Interleukin-1 Transcriptional Response by the Interaction between VRK2 and the JIP1 Scaffold Protein , 2008, PloS one.

[9]  F. Collart,et al.  A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. , 2002, Protein expression and purification.

[10]  S. Kimura,et al.  Autophosphorylation of β-connectin (titin 2) in vitro , 1992 .

[11]  Kyong-Tai Kim,et al.  Mitotic Histone H3 Phosphorylation by Vaccinia-Related Kinase 1 in Mammalian Cells , 2007, Molecular and Cellular Biology.

[12]  R. Durbin,et al.  GeneWise and Genomewise. , 2004, Genome research.

[13]  J. Nezu,et al.  Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. , 1997, Genomics.

[14]  W. Gullick,et al.  Identification of c‐erbB‐3 binding sites for phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera. , 1994, The EMBO journal.

[15]  Kyong-Tai Kim,et al.  VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues. , 2008, Biochimica et biophysica acta.

[16]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Lynn F. Ten Eyck,et al.  A helix scaffold for the assembly of active protein kinases , 2008, Proceedings of the National Academy of Sciences.

[18]  T. Hunter,et al.  The mouse kinome: discovery and comparative genomics of all mouse protein kinases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Stark,et al.  IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.

[20]  Itay Mayrose,et al.  ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures , 2005, Nucleic Acids Res..

[21]  W. Kolch Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.

[22]  P. Lazo,et al.  Human VRK1 Is an Early Response Gene and Its Loss Causes a Block in Cell Cycle Progression , 2008, PloS one.

[23]  Gerard Manning,et al.  Structural and Functional Diversity of the Microbial Kinome , 2007, PLoS biology.

[24]  A. Sevilla,et al.  Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. , 2007, Archives of biochemistry and biophysics.

[25]  Claudio R. Santos,et al.  Vaccinia-Related Kinase 2 Modulates the Stress Response to Hypoxia Mediated by TAK1 , 2007, Molecular and Cellular Biology.

[26]  T. Hunter,et al.  Evolution of protein kinase signaling from yeast to man. , 2002, Trends in biochemical sciences.

[27]  K. Longenecker,et al.  Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition. , 1996, Journal of molecular biology.

[28]  D. Morrison,et al.  KSR: a MAPK scaffold of the Ras pathway? , 2001, Journal of cell science.

[29]  Susan S. Taylor,et al.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.

[30]  C. Gibbs,et al.  Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. , 1991, The Journal of biological chemistry.

[31]  J. Adams,et al.  Nucleotide-induced conformational changes in the Saccharomyces cerevisiae SR protein kinase, Sky1p, revealed by X-ray crystallography. , 2003, Biochemistry.

[32]  David L. Wheeler,et al.  GenBank , 2015, Nucleic Acids Res..

[33]  Chung F. Wong,et al.  The structure of Sky1p reveals a novel mechanism for constitutive activity , 2001, Nature Structural Biology.

[34]  Liisa Holm,et al.  DaliLite workbench for protein structure comparison , 2000, Bioinform..

[35]  R. Russell,et al.  Functional Analysis of H-Ryk, an Atypical Member of the Receptor Tyrosine Kinase Family , 1999, Molecular and Cellular Biology.

[36]  Daumantas Matulis,et al.  Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. , 2005, Biochemistry.

[37]  Kathleen A. Boyle,et al.  Mutant Defective in the B 1 Kinase ts Virus DNA-Negative Phenotype of a Vaccinia Protein Kinases Complement the Members of a Novel Family of Mammalian , 2004 .

[38]  H. Shih,et al.  Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival. , 2006, The Journal of general virology.

[39]  S. Knapp,et al.  Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. , 2005, Journal of medicinal chemistry.

[40]  R M Sweet,et al.  Crystal structure of casein kinase‐1, a phosphate‐directed protein kinase. , 1995, The EMBO journal.

[41]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[42]  A. Prescott,et al.  Analysis of the LKB1-STRAD-MO25 complex , 2004, Journal of Cell Science.

[43]  R. Steele,et al.  Deceiving appearances: signaling by “dead” and “fractured” receptor protein‐tyrosine kinases , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[45]  L. Berg,et al.  A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. , 1996, Oncogene.

[46]  Philip E. Bourne,et al.  Structural Evolution of the Protein Kinase–Like Superfamily , 2005, PLoS Comput. Biol..

[47]  Paul Young,et al.  Structural basis for activation of the titin kinase domain during myofibrillogenesis , 1998, Nature.

[48]  Jack Snoeyink,et al.  MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007, Nucleic Acids Res..

[49]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[50]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[51]  Jonathan Bard,et al.  Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. , 2004, Analytical biochemistry.

[52]  A. R. Shenoy,et al.  The kinase homology domain of receptor guanylyl cyclase C: ATP binding and identification of an adenine nucleotide sensitive site. , 2006, Biochemistry.

[53]  P. Lazo,et al.  Proteomics Identification of Nuclear Ran GTPase as an Inhibitor of Human VRK1 and VRK2 (Vaccinia-related Kinase) Activities , 2008, Molecular & Cellular Proteomics.

[54]  P. Lazo,et al.  The subcellular localization of vaccinia‐related kinase‐2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines , 2006, The FEBS journal.

[55]  Kyong-Tai Kim,et al.  Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase , 2006, Nature Cell Biology.

[56]  Claudio R. Santos,et al.  Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK* , 2004, Journal of Biological Chemistry.

[57]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[58]  Wolfgang Kabsch,et al.  Integration, scaling, space‐group assignment and post refinement , 2006 .

[59]  Susan S. Taylor,et al.  Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase , 2002, Nature Structural Biology.

[60]  R. Nichols,et al.  The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. , 2006, Molecular biology of the cell.

[61]  D. Bossemeyer,et al.  The glycine-rich sequence of protein kinases: a multifunctional element. , 1994, Trends in biochemical sciences.

[62]  P. Lazo,et al.  Expression of the VRK (vaccinia‐related kinase) gene family of p53 regulators in murine hematopoietic development , 2003, FEBS letters.

[63]  S. Taylor,et al.  Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase. , 1998, Biochemistry.

[64]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[65]  P. Lazo,et al.  The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein , 2000, Oncogene.

[66]  Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. , 2004, Structure.